CRVL
Neutral signalScored 2026-09-05 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
CorVel Corporation
- Nom
- CorVel Corporation
- Secteur
- Financial Services
- Industrie
- Insurance - Brokers
- Bourse
- NASDAQ
- Capitalisation
- $4.3B
- Employés
- 5,239
- PDG
- Sarah Scott
- Site web
- https://www.corvel.com
- Marché
- CTEVEVHHQY
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 6 847 titres (~481 488,31 $ US)
- Insiders
- JESSUP R JUDD
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$16,296,946
Avg sell (VWAP, 90d window) $69.66 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$15,666,537 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-09-01
- Last synced
-
2026-09-07 10:23:47
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-14 | CORSTAR HOLDINGS INC | Sell · S · 10b5-1 | 127,824 | $70.16 | $8,968,055 | Form 4 |
| 2026-09-11 | CORSTAR HOLDINGS INC | Sell · S · 10b5-1 | 30,925 | $69.05 | $2,135,303 | Form 4 |
| 2026-09-04 | CORSTAR HOLDINGS INC | Sell · S · 10b5-1 | 14,538 | $68.76 | $999,573 | Form 4 |
| 2026-09-03 | CORSTAR HOLDINGS INC | Sell · S · 10b5-1 | 51,713 | $68.91 | $3,563,605 | Form 4 |
| 2026-09-01 | JESSUP R JUDD | Sell · S | 4,023 | $70.07 | $281,892 | Form 4 |
| 2026-08-27 | JESSUP R JUDD | Sell · S | 1,262 | $70.64 | $89,148 | Form 4 |
| 2026-08-26 | JESSUP R JUDD | Sell · S | 1,562 | $70.71 | $110,449 | Form 4 |
| 2026-08-20 | Yoss Jennifer | Sell · S | 2,100 | $70.92 | $148,922 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-09-05 Drivers: fundamentals. Moteurs : fondamentaux.
CRVL exhibits genuinely strong fundamentals — high ROE/ROIC, solid liquidity, and improving margins — but the event-driven signal is decisively bearish, with a catalyst score of only 20 driven by meaningful insider…
The first sentence of the analysis written for CRVL on 2026-09-05 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 2.03 · operating margin 15%
Market snapshot
Financial ratios
| Metric | Trend | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 24.3% | 23.4% | 21.6% | 22.0% | 23.5% | |
| Ebit Margin | 14.9% | 13.5% | 12.0% | 11.8% | 13.1% | |
| Ebitda Margin | 18.2% | 16.8% | 15.3% | 15.3% | 16.8% | |
| Operating Profit Margin | 14.9% | 13.5% | 12.0% | 11.8% | 13.1% | |
| Pretax Profit Margin | 14.9% | 13.5% | 12.0% | 11.8% | 13.1% | |
| Continuous Operations Profit Margin | 11.5% | 10.6% | 9.6% | 9.2% | 10.3% | |
| Net Profit Margin | 11.5% | 10.6% | 9.6% | 9.2% | 10.3% | |
| Bottom Line Profit Margin | 11.5% | 10.6% | 9.6% | 9.2% | 10.3% | |
| Current Ratio | 2.027 | 1.895 | 1.638 | 1.452 | 1.546 | |
| Quick Ratio | 2.027 | 1.895 | 1.638 | 1.452 | 1.546 | |
| Solvency Ratio | 0.571 | 0.557 | 0.495 | 0.477 | 0.445 | |
| Cash Ratio | 1.022 | 0.836 | 0.572 | 0.425 | 0.569 | |
| Price To Earnings Ratio | 25.419 | 60.524 | 57.824 | 49.555 | 44.920 | |
| Price To Earnings Growth Ratio | 1.567 | 2.421 | 3.701 | 20.648 | -0.898 | |
| Forward Price To Earnings Growth Ratio | 1.567 | 2.421 | 3.701 | 20.648 | -0.898 | |
| Price To Earnings Diluted Ratio | 25.537 | 61.186 | 58.218 | 50.341 | 46.025 | |
| Price To Earnings Diluted Growth Ratio | 1.508 | 2.498 | 3.493 | 15.354 | -0.899 | |
| Price To Book Ratio | 7.109 | 17.870 | 17.751 | 16.309 | 14.080 | |
| Price To Sales Ratio | 2.924 | 6.425 | 5.527 | 4.589 | 4.628 | |
| Price To Free Cash Flow Ratio | 25.413 | 62.843 | 62.801 | 58.915 | 79.953 | |
| Price To Operating Cash Flow Ratio | 18.007 | 45.194 | 44.297 | 40.071 | 44.487 | |
| Debt To Assets Ratio | 0.044 | 0.051 | 0.069 | 0.086 | 0.104 | |
| Debt To Equity Ratio | 0.071 | 0.087 | 0.127 | 0.167 | 0.203 | |
| Debt To Capital Ratio | 0.067 | 0.080 | 0.113 | 0.143 | 0.169 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.631 | 1.696 | 1.836 | 1.948 | 1.955 | |
| Working Capital Turnover Ratio | 4.599 | 5.963 | 8.215 | 8.478 | 6.459 | |
| Operating Cash Flow Ratio | 0.682 | 0.624 | 0.538 | 0.490 | 0.392 | |
| Operating Cash Flow Sales Ratio | 0.162 | 0.142 | 0.125 | 0.115 | 0.104 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.709 | 0.719 | 0.705 | 0.680 | 0.556 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 5.537 | 4.534 | 3.161 | 2.437 | 1.558 | |
| Capital Expenditure Coverage Ratio | 3.431 | 3.561 | 3.394 | 3.126 | 2.254 | |
| Dividend Paid And Capex Coverage Ratio | 3.431 | 3.561 | 3.394 | 3.126 | 2.254 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 14.853 | 37.320 | 35.613 | 29.722 | 27.079 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 24.3% | ▲0.9% | ▲1.3% |
| Ebit Margin | 14.9% | ▲1.4% | ▲1.9% |
| Ebitda Margin | 18.2% | ▲1.5% | ▲1.8% |
| Operating Profit Margin | 14.9% | ▲1.4% | ▲1.9% |
| Pretax Profit Margin | 14.9% | ▲1.4% | ▲1.9% |
| Continuous Operations Profit Margin | 11.5% | ▲0.9% | ▲1.3% |
| Net Profit Margin | 11.5% | ▲0.9% | ▲1.3% |
| Bottom Line Profit Margin | 11.5% | ▲0.9% | ▲1.3% |
| Current Ratio | 2.027 | ▲0.132 | ▲0.315 |
| Quick Ratio | 2.027 | ▲0.132 | ▲0.315 |
| Solvency Ratio | 0.571 | ▲0.015 | ▲0.062 |
| Cash Ratio | 1.022 | ▲0.186 | ▲0.337 |
| Price To Earnings Ratio | 25.419 | ▼-35.106 | ▼-22.230 |
| Price To Earnings Growth Ratio | 1.567 | ▼-0.854 | ▼-3.920 |
| Forward Price To Earnings Growth Ratio | 1.567 | ▼-0.854 | ▼-3.920 |
| Price To Earnings Diluted Ratio | 25.537 | ▼-35.648 | ▼-22.724 |
| Price To Earnings Diluted Growth Ratio | 1.508 | ▼-0.991 | ▼-2.883 |
| Price To Book Ratio | 7.109 | ▼-10.761 | ▼-7.515 |
| Price To Sales Ratio | 2.924 | ▼-3.501 | ▼-1.895 |
| Price To Free Cash Flow Ratio | 25.413 | ▼-37.430 | ▼-32.572 |
| Price To Operating Cash Flow Ratio | 18.007 | ▼-27.187 | ▼-20.404 |
| Debt To Assets Ratio | 0.044 | ▼-0.008 | ▼-0.027 |
| Debt To Equity Ratio | 0.071 | ▼-0.016 | ▼-0.060 |
| Debt To Capital Ratio | 0.067 | ▼-0.014 | ▼-0.048 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.631 | ▼-0.065 | ▼-0.182 |
| Working Capital Turnover Ratio | 4.599 | ▼-1.364 | ▼-2.144 |
| Operating Cash Flow Ratio | 0.682 | ▲0.058 | ▲0.137 |
| Operating Cash Flow Sales Ratio | 0.162 | ▲0.020 | ▲0.033 |
| Free Cash Flow Operating Cash Flow Ratio | 0.709 | ▼-0.011 | ▲0.035 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 5.537 | ▲1.003 | ▲2.092 |
| Capital Expenditure Coverage Ratio | 3.431 | ▼-0.129 | ▲0.278 |
| Dividend Paid And Capex Coverage Ratio | 3.431 | ▼-0.129 | ▲0.278 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 14.853 | ▼-22.467 | ▼-14.065 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $2.80B | $5.75B | $4.40B | $3.30B | $2.99B | |
| Enterprise value | $2.60B | $5.61B | $4.32B | $3.26B | $2.94B | |
| EV / Sales | 2.71x | 6.27x | 5.43x | 4.54x | 4.54x | |
| EV / Op. cash flow | 16.69x | 44.08x | 43.55x | 39.61x | 43.68x | |
| EV / Free cash flow | 23.55x | 61.29x | 61.74x | 58.24x | 78.50x | |
| EV / EBITDA | 14.85x | 37.32x | 35.61x | 29.72x | 27.08x | |
| Net debt / EBITDA | -1.17x | -0.95x | -0.61x | -0.34x | -0.50x | |
| Current ratio | 2.03x | 1.90x | 1.64x | 1.45x | 1.55x | |
| Income quality | 1.41x | 1.34x | 1.30x | 1.24x | 1.01x | |
| Graham number | $19 | $16 | $13 | $11 | $11 | |
| Graham net-net | $1 | $0 | -$1 | -$1 | -$1 | |
| Tax burden | 77.1% | 78.8% | 80.2% | 78.5% | 78.6% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $234.2M | $182.7M | $117.7M | $75.9M | $93.6M | |
| Invested capital | $410.4M | $332.8M | $265.3M | $224.4M | $243.4M | |
| Return on assets | 17.2% | 17.4% | 16.8% | 16.8% | 16.0% | |
| Operating ROA | 24.1% | 24.1% | 22.4% | 20.9% | 20.1% | |
| Return on tangible assets | 18.2% | 18.7% | 18.3% | 18.6% | 17.6% | |
| Return on equity | 28.0% | 29.6% | 30.8% | 32.8% | 31.3% | |
| Return on invested capital | 26.1% | 27.2% | 27.3% | 28.1% | 25.8% | |
| Return on capital employed | 34.5% | 35.3% | 35.2% | 37.4% | 34.7% | |
| Earnings yield | 3.9% | 1.7% | 1.7% | 2.0% | 2.2% | |
| Free cash flow yield | 3.9% | 1.6% | 1.6% | 1.7% | 1.3% | |
| Capex / Op. cash flow | 29.1% | 28.1% | 29.5% | 32.0% | 44.4% | |
| Capex / Depreciation | 142.8% | 121.1% | 111.4% | 104.8% | 124.7% | |
| Capex / Sales | 4.7% | 4.0% | 3.7% | 3.7% | 4.6% | |
| SG&A / Sales | 9361.4% | 9.9% | 9.6% | 10.3% | 10.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.6% | 0.6% | 0.6% | 0.8% | 0.8% | |
| Intangibles / Total assets | 5.8% | 6.8% | 8.3% | 9.7% | 9.3% | |
| Days sales outstanding | 39d | 42d | 45d | 41d | 47d | |
| Days payables outstanding | 12d | 8d | 10d | 10d | 10d | |
| Operating cycle | 39d | 42d | 45d | 41d | 47d | |
| Cash conversion cycle | 26d | 34d | 35d | 31d | 36d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-09-03 Head to Head Analysis: CorVel (NASDAQ:CRVL) versus Wellgistics Health (NASDAQ:MEDS) Wellgistics Health (NASDAQ: MEDS - Get Free Report) and CorVel (NASDAQ: CRVL - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Earnings and Valuation This table compares Wellgistics Health and
- 2026-08-12 Assenagon Asset Management S.A. Sells 95,906 Shares of CorVel Corp. $CRVL Assenagon Asset Management S.A. reduced its stake in CorVel Corp. (NASDAQ: CRVL) by 48.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 101,952 shares of the business services provider''s stock after selling 95,906 shares during the period.
- 2026-08-05 CorVel Corporation (CRVL) Q1 2027 Earnings Call Prepared Remarks Transcript CorVel Corporation (CRVL) Q1 2027 Earnings Call Prepared Remarks Transcript
- 2026-08-05 CorVel Q1 Earnings Call Highlights CorVel NASDAQ: CRVL reported June-quarter revenue of $260 million, up 11% from $235 million in the June 2025 quarter, while earnings per share rose 22% to $0.63 from $0.52 a year earlier.
- 2026-08-05 CorVel Announces Revenues and Earnings FORT WORTH, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2026. Revenues for the quarter were $260 million, an increase from $235 million in the June quarter of 2025. Earnings per share for the quarter were $0.63, compared to $0.52 in the same quarter of the prior year.
- 2026-07-27 CorVel Corporation to Host Live Earnings Release Webcast FORT WORTH, Texas, July 27, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Wednesday, August 5, 2026, at 11:30 AM Eastern Time.
- 2026-07-08 CorVel Named 2026 PropertyCasualty360 Insurance Luminaries Winner for Excellence in Claims Management CorVel earned the 2026 PropertyCasualty360 Insurance Luminaries Award for Excellence in Claims Management for its integrated, technology-enabled approach.
- 2026-06-17 CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs. As medical billing continues to vary widely across states, providers, and care settings, traditional network and re-pricing approaches do not always reflect market pricing.